Deconstructing the $600 Million Man: An Analytical Report on the Net Worth of Michael Polansky

Part I: Executive Summary & The Central Question

Numerous media outlets and financial publications have converged on a singular figure for the net worth of entrepreneur and investor Michael Polansky: an estimated $600 million.¹

This figure, often mentioned in the context of his engagement to global superstar Lady Gaga, presents him as a formidable financial power, doubling the estimated wealth of his fiancée.¹

While widely circulated, this number exists largely without public substantiation, a common characteristic for the wealth of private individuals operating outside the direct scrutiny of public markets.

This report seeks to move beyond the headline figure to conduct a rigorous, bottom-up analysis of its composition and plausibility.

The central question of this investigation is not merely to verify the $600 million estimate, but to deconstruct its potential origins.

Michael Polansky’s financial profile is built upon three distinct yet interconnected pillars, each contributing to his wealth in a unique Way. This report will systematically analyze each pillar:

1. The Operator: Polansky’s most significant and perhaps most opaque role is as the chief executive and architect of the Parker empire. As CEO of The Parker Group, he is tasked with translating the vision of tech billionaire Sean Parker into functional, large-scale organizations across technology, life sciences, public policy, and philanthropy.⁵ This role positions him as a high-level operational partner to one of Silicon Valley’s most influential figures.
2. The Investor: Separate from his duties for Parker, Polansky has established himself as a principal in his own right, co-founding his own investment firms. These ventures, including Avos Capital Management and Hawktail, represent direct, personal asset-building vehicles operating in both public and private markets.⁷
3. The Founder: Beyond managing the capital of others, Polansky has taken a direct entrepreneurial role as the co-founder and CEO of Outer Biosciences, a biotech startup.⁷ This position affords him a substantial founder’s equity stake, representing a significant, albeit illiquid, component of his potential wealth.

The analytical objective of this report is to construct a valuation model based on publicly available data, established industry benchmarks, and a sophisticated understanding of private capital structures.

By examining the likely value generated from each of these three pillars, this analysis will assess the plausibility of the $600 million consensus figure and provide a more granular, evidence-based perspective on Michael Polansky’s financial standing.

The final assessment will offer a reasoned conclusion on whether the popular estimate is credible, optimistic, or potentially conservative, given the available information.

Part II: The Methodology of Valuing Private Wealth

Before deconstructing the specific assets of Michael Polansky, it is imperative to establish the analytical framework used to value the holdings of high-net-worth individuals whose interests are predominantly private.

This section outlines the core principles, valuation techniques, and inherent limitations of such an assessment, providing the methodological foundation for the remainder of the report.

Core Principles and Primary Challenges

The fundamental equation for determining net worth is deceptively simple: Assets – Liabilities = Net Worth.¹⁰

An individual’s assets represent everything they own that has monetary value, while liabilities encompass all that they owe.

A positive net worth indicates that assets exceed liabilities, signaling financial health, whereas a negative net worth suggests the opposite.¹¹

The primary challenge in applying this formula to a private individual like Polansky is the fundamental opacity of their finances.

Unlike executives of publicly traded companies, whose stock ownership is often detailed in mandatory filings with the Securities and Exchange Commission (SEC), the assets and liabilities of private individuals are not subject to public disclosure.¹³

Consequently, any external valuation must rely on a combination of investigative research, inference from available data, and the application of standardized industry benchmarks.

This process is inherently an estimation, not an exact accounting.¹⁶

Valuation Techniques for Private Assets

To navigate the scarcity of direct data, financial analysts employ several established techniques to estimate the value of private assets.

Private Company Valuation: The value of a privately held company is often estimated using Comparable Company Analysis (CCA).

This method involves identifying publicly traded companies that are similar in industry, size, and growth profile.

Analysts then calculate valuation multiples for these public “comps”—such as Price-to-Earnings (P/E) or Enterprise Value-to-EBITDA (EV/EBITDA)—and apply them to the private company’s financial metrics to derive an estimated value.¹⁶

This approach is powerful but requires careful selection of comparables and adjustments for differences between the public and private entities.

Venture Capital and Startup Valuation: Early-stage companies, particularly in the technology and biotech sectors, are typically valued based on their most recent financing rounds.

The post-money valuation is calculated after an investment and provides a clear benchmark of how investors have priced the company.

For example, if a venture capital firm invests $5 million for a 20% stake, the implied post-money valuation of the company is $25 million.¹⁸

The Illiquidity Discount: A critical concept in private asset valuation is the discount for lack of marketability.

Shares in a private company cannot be easily sold on an open market like public stocks.

This illiquidity represents a significant risk for the holder.

To account for this, analysts apply an illiquidity discount, often ranging from 20% to 30% or more, to the estimated value of the private asset.

This adjustment reflects the lower price a buyer would be willing to pay for an asset that cannot be quickly converted to cash.¹⁵

Key Compensation Structures and Wealth Drivers

For top-tier executives and fund managers in the private sphere, wealth is generated through specific compensation structures that are often invisible to the public.

Carried Interest: This is arguably the most significant wealth-creation mechanism for managers of private equity and venture capital funds.

“Carry” is the share of the fund’s profits—typically 20%—that the general partners (the managers) receive after returning the initial capital to the limited partners (the investors).

While an individual’s salary and management fees provide steady income, carried interest from successful investments can result in immense, multi-million-dollar payouts upon the “exit” (sale or IPO) of portfolio companies.²⁰

This is a primary, albeit delayed and contingent, source of wealth.

Executive Compensation in Private vs. Public Companies: Executive compensation in private companies is fundamentally different from that in public ones.

Public company pay structures are transparent and often include a mix of salary, cash bonuses, and equity awards (like stock options and restricted stock units) tied to publicly reported performance metrics.²¹

Private company compensation, especially in high-growth or PE-backed firms, is heavily weighted toward long-term value creation.

It often involves a lower cash component but a much larger grant of direct equity or profit-sharing interests that align the executive’s financial outcome directly with the success of the enterprise, realized upon a future liquidity event.²⁰

The Unknown Variable: Liabilities

The final and most significant limitation of any external net worth estimation is the near-total absence of information on an individual’s liabilities.

While assets can be estimated with a degree of confidence, personal and professional debts—such as mortgages, personal loans, lines of credit, and, crucially, capital commitments to investment funds—remain unknown.¹¹

Therefore, any publicly cited net worth figure is almost certainly a gross estimation of assets rather than a true net worth calculation.

This report will focus on estimating the asset side of the ledger while acknowledging that the liability side remains an unquantifiable variable.

Part III: Pillar 1 – The Operator: Architect of the Parker Empire

The most significant and foundational pillar of Michael Polansky’s wealth is his role as the chief executive officer of The Parker Group.

This position places him at the nexus of the vast and complex financial, philanthropic, and political interests of Sean Parker, the co-founder of Napster and an early president of Facebook.²

Understanding this role is critical to understanding the primary engine of his wealth accumulation.

Role Definition: More Than a Manager

Polansky’s title of CEO belies the true nature of his function.

According to professional profiles, his role is to “build the business, organizational, or investment models to support Sean’s vision” across a wide array of fields, including technology, life sciences, economic development, and civic engagement.⁵

This description casts him not merely as a manager of existing assets but as a systems architect—the operational partner responsible for translating a billionaire’s ambitious and diverse objectives into tangible, functioning enterprises.

Since joining Parker, Polansky has been instrumental in building a large portfolio of private technology companies and has co-founded several major initiatives.⁶

His career trajectory, from an investment associate at the prestigious hedge fund Bridgewater and a principal at Peter Thiel’s Founders Fund to his current role, demonstrates a deep immersion in the worlds of high finance and technology investing.⁵

This background equips him with the rare combination of financial acumen and operational expertise required to oversee a portfolio as complex as Parker’s.

Case Study in Scale: The Parker Institute for Cancer Immunotherapy (PICI)

To comprehend the scale of the operations Polansky oversees, the Parker Institute for Cancer Immunotherapy (PICI) serves as a powerful case study.

Polansky is a co-founder and board member of PICI, which was launched in 2016 with an unprecedented $250 million grant from the Parker Foundation.¹

The Parker Foundation itself, of which Polansky is the Executive Director, was established with an initial gift of

$600 million.²²

PICI’s mission is to accelerate the development of breakthrough immune therapies by fostering collaboration among leading research institutions, including Memorial Sloan Kettering, Stanford, UCSF, and UCLA.⁷

Publicly available Form 990 tax filings for the nonprofit provide a transparent window into its financial magnitude.

Parker Institute for Cancer Immunotherapy (PICI) Financial Snapshot
Fiscal Year
2023
2022
2021
Source: ProPublica analysis of Form 990 filings 25

This data accomplishes two critical analytical tasks.

First, it provides concrete, verifiable evidence of the immense scale and complexity of the organizations Polansky is responsible for co-founding and governing.

Managing an entity with over a quarter-billion dollars in assets and coordinating a network of the world’s top scientists is a task reserved for elite executives.

Second, and more importantly, the filings confirm that Polansky receives $0 in direct compensation from this major philanthropic entity.²⁵

This is a crucial finding.

It strongly indicates that his remuneration for his work within the Parker ecosystem does not come from the nonprofit arms.

Instead, his wealth must be generated from the

for-profit ventures within The Parker Group.

Valuation Analysis: Estimating Compensation from For-Profit Ventures

Given that The Parker Group is a private entity, no public records detail Polansky’s compensation package.⁶

Therefore, the analysis must rely on industry benchmarks for executives in comparable roles, such as CEOs of multi-billion-dollar family offices or senior partners at major private equity firms.

The compensation for such a role would typically consist of three components:

1. Base Salary: A significant annual salary, likely in the seven-figure range, commensurate with the responsibilities of managing a multi-billion-dollar portfolio of interests.
2. Annual Performance Bonus: A substantial cash bonus tied to the performance of the investments and the successful execution of strategic initiatives.
3. Long-Term Incentives (Carried Interest/Equity): This is the most significant component of his earnings. For his role in identifying, structuring, and managing for-profit investments for Parker, Polansky would almost certainly receive a form of carried interest or direct equity participation. This aligns his financial success directly with Parker’s and provides the mechanism for accumulating wealth on the order of hundreds of millions of dollars over a decade-plus tenure.

While the exact percentage is unknown, a share of profits from a portfolio built alongside a tech billionaire like Sean Parker—whose early involvement in companies like Facebook and Spotify created legendary returns—is the most logical explanation for the foundation of a $600 million net worth.

The value of this pillar is not in an annual salary, but in the capitalized value of his share of a decade’s worth of successful, high-growth private investments.

Part IV: Pillar 2 – The Investor: Building His Own Funds

Beyond his foundational role as the operator of the Parker empire, Michael Polansky has strategically diversified his activities by establishing himself as a principal and founder of his own investment firms.

These entities represent a second, distinct pillar of his wealth, where he is not just managing capital for others but is actively building his own asset management businesses.

This demonstrates a clear evolution from a trusted executive to an independent financial entrepreneur.

His ventures in this space are bifurcated into two different strategies: a liquid public-market fund and an illiquid, high-growth venture capital firm.

Firm 1: Avos Capital Management

Co-founded by Polansky in January 2021, Avos Capital Management operates as a hedge fund or investment advisory firm.⁷

The firm’s strategy focuses on managing portfolios of publicly traded securities across a range of asset classes, including equities, fixed income, commodities, and currencies.

It primarily utilizes exchange-traded funds (ETFs) for efficient market exposure, indicating a strategy geared towards diversified, liquid investments.²⁶

Public filings provide a clear view of the firm’s scale.

As of early 2025, Avos Capital Management reported a total of $252.92 million in Assets Under Management (AUM).²⁶

Its most recent 13F filing, which discloses its long positions in publicly traded US securities, showed a portfolio value of approximately

$154.7 million.²⁷

The difference between total AUM and the 13F portfolio value likely represents assets held in other forms, such as cash, international securities, or short positions, which are not required to be disclosed in 13F filings.

The value of Polansky’s stake in Avos Capital can be estimated using the standard “2 and 20” compensation model common in the hedge fund industry.

This model consists of:

• A 2% management fee on total AUM, which provides a steady, predictable revenue stream for the firm’s operations. On $252.92 million AUM, this would generate approximately $5.06 million in annual revenue.
• A 20% performance fee (carried interest) on any profits the fund generates for its investors. This component is variable and dependent on performance but represents the primary profit driver.

As a co-founder, Polansky holds a significant equity stake in the management company, entitling him to a substantial share of this fee-based revenue and performance allocation.

Firm 2: Hawktail

In parallel with his public-market activities at Avos, Polansky founded Hawktail, a venture capital firm that embodies a classic early-stage investment strategy.⁸

Hawktail focuses on providing seed and early-stage funding to what it terms “transformational technology” companies across sectors like life sciences, climate tech, deep tech, and software-as-a-service (SaaS).⁸

Hawktail is a highly active firm.

Data from Pitchbook indicates it has made over 100 investments and has seen at least 6 exits from its portfolio, which is the first point at which venture capital investments generate realized returns.³¹

The firm has raised capital through multiple funds.

For instance, its “HAWKTAIL II, L.P.” fund reported raising

$27.7 million from investors.³²

Across its various private funds, Hawktail is reported to have a total Gross Asset Value of

$48.12 million.³²

The valuation of Polansky’s stake in Hawktail follows the venture capital model.

The firm earns management fees on its committed capital (its AUM), providing operational income.

However, the vast majority of potential wealth is locked in its carried interest.

As the firm’s 100+ portfolio companies mature, successful exits via acquisition or IPO will generate profits, and as the founder, Polansky is entitled to a significant portion of the 20% carry.

While most of this value is currently unrealized and illiquid, the six documented exits signify that the process of generating returns has begun.

The concurrent operation of Avos and Hawktail reveals a highly sophisticated personal wealth diversification strategy.

Avos provides a stable foundation with predictable, fee-based revenue from liquid public markets.

Hawktail, in contrast, is a high-risk, high-reward engine designed for long-term, exponential wealth creation through illiquid, early-stage bets.

This dual approach balances immediate income with the potential for massive future payouts, a hallmark of a seasoned financial professional building a durable personal enterprise.

Table: Estimated Valuation of Personal Investment Holdings

Firm

Avos Capital

Hawktail

Note: The value of Polansky’s stake is an estimation based on industry-standard structures.

The actual value depends on his specific ownership percentage, the performance of the funds, and the terms of the partnership agreements, which are not public.

Part V: Pillar 3 – The Founder: Direct Entrepreneurial Equity

The third pillar of Michael Polansky’s financial profile distinguishes him from many traditional investors and executives: he is not only a manager of capital but also a direct founder and operator of a technology startup.

His role as co-founder and chief executive officer of Outer Biosciences represents a significant source of potential wealth in the form of founder’s equity, the most concentrated and potentially lucrative class of ownership in a successful venture.

Venture Profile: Outer Biosciences

Michael Polansky is listed as the Co-Founder and CEO of Outer Biosciences, a biotechnology company he helped establish in 2020.⁷

This is not a passive board seat or an advisory role; as CEO, he is responsible for the company’s day-to-day leadership and strategic direction.

This hands-on involvement strongly implies that he holds a substantial equity stake, typical for a founding CEO.

Outer Biosciences operates at the intersection of biology and technology.

Its mission is to discover and develop novel bioactive compounds for skin health by using a proprietary platform that combines advanced, long-lasting ex vivo skin models with multimodal data analysis and predictive machine learning.⁹

This science-based approach aims to identify effective and safe ingredients for health and cosmetic products at an unprecedented scale.

Financials and Valuation Analysis

As an early-stage private company, Outer Biosciences’ financials are not public.

Its valuation is best estimated through its funding history.

There is, however, a notable discrepancy in the publicly available data regarding its financing:

• Several sources, including Pitchbook and Tracxn, report that Outer Biosciences raised a $4 million Series A funding round.³⁵
• Another source, WorkInBiotech, reports a higher total funding amount of $22 million, comprising both seed and Series A rounds.³³

This discrepancy is significant as the valuation of Polansky’s stake is directly tied to the company’s post-money valuation, which is derived from these funding rounds.

To conduct a thorough analysis, it is necessary to consider both scenarios.

The valuation of his founder’s equity would be a significant percentage of the company’s total equity, minus the portion sold to investors.

This stake is highly illiquid and its value is contingent on the company’s future success, but it represents a major asset on his personal balance sheet.

Table: Estimated Valuation of Founder’s Equity in Outer Biosciences

Valuation Scenario

Scenario A

Scenario B

Note: Post-money valuations are estimates based on typical early-stage funding structures where investors might acquire 15-25% of a company.

The actual valuation and Polansky’s ownership percentage are private.

The existence of Outer Biosciences within Polansky’s portfolio raises compelling strategic questions.

It is highly unusual for an individual to serve as the CEO of a demanding entity like The Parker Group while simultaneously acting as the hands-on CEO of a startup.

This suggests that Outer Biosciences may not be a simple “side project.” Given the Parker Foundation’s stated, capital-intensive focus on Life Sciences ⁵, it is plausible that Outer Biosciences is a venture that is strategically aligned with, or was perhaps even incubated within, the Parker ecosystem.

This would create a synergistic relationship where the startup benefits from the capital, network, and strategic guidance of the Parker empire, while Polansky is uniquely positioned to build direct, personal founder-level wealth in a domain of core interest to his primary role.

This reframes Outer Biosciences from a separate endeavor into a key, value-creating node within his broader professional universe.

Part VI: Synthesis & Final Assessment: Re-evaluating the $600 Million Figure

Having deconstructed the three core pillars of Michael Polansky’s financial life—his role as an operator for Sean Parker, his activities as an investor through his own funds, and his position as a founder of a biotech startup—it is now possible to synthesize these components into a consolidated assessment.

This final analysis will aggregate the estimated values from each pillar to evaluate the plausibility of the widely cited $600 million net worth figure.

Consolidated Asset Estimation

The following table provides a summary balance sheet, bringing together the estimated values of Polansky’s major assets.

It is crucial to reiterate that this is an estimation of the asset side of the ledger.

The liability side, which includes personal debts, mortgages, and potential capital commitments to his funds, remains unknown and would reduce the final net worth figure.

Table: Estimated Net Worth Calculation for Michael Polansky

ASSETS

Pillar 1: The Operator (The Parker Group)

* Cumulative Estimated Compensation (Salary + Bonus)

* Estimated Value of Carried Interest/Equity from Parker Investments

Pillar 2: The Investor (Personal Funds)

* Estimated Value of Stake in Avos Capital Management

* Estimated Value of Stake in Hawktail

Pillar 3: The Founder (Direct Equity)

* Estimated Value of Founder’s Equity in Outer Biosciences

Other Assets

* Board Seats & Miscellaneous

TOTAL ESTIMATED ASSETS (Pre-Liabilities)

LIABILITIES

Conclusion: Plausibility of the $600 Million Figure

Based on the bottom-up analysis of his known professional activities, the publicly cited net worth of $600 million for Michael Polansky appears plausible, though it sits at the higher end of the estimated range and is heavily contingent on several key assumptions.

1. Dependence on the Parker Partnership: The analysis demonstrates that it is nearly impossible to reach a figure approaching $600 million without assuming an extraordinarily successful and lucrative partnership with Sean Parker. The wealth generated from his personal funds (Avos, Hawktail) and his startup (Outer Biosciences), while substantial, likely accounts for a smaller fraction of the total. The vast majority of the $600 million figure must be attributed to the value of carried interest or equity he has earned from over a decade of architecting and executing the for-profit investment strategy of The Parker Group.
2. The Illiquidity Factor: A significant portion of Polansky’s estimated assets is tied up in illiquid holdings, primarily his unrealized carried interest in Hawktail’s venture portfolio, his founder’s equity in Outer Biosciences, and his share of private Parker Group investments. The “on-paper” value of these assets could be immense, but their actual cash value is not realized until a liquidity event (an acquisition or IPO). The $600 million figure likely represents this on-paper valuation and does not account for the deep discounts that would apply if these assets needed to be liquidated quickly.
3. A Conservative View vs. an Optimistic One: A conservative estimate, based only on more tangible assets like his stake in Avos Capital and a modest valuation of his other ventures, would place his net worth well below $600 million. Conversely, an optimistic view—assuming that his share of the Parker ventures is substantial and that his Hawktail portfolio contains several future “unicorn” companies—could easily support and even exceed the $600 million mark.

Final Thematic Summary

This report deconstructs the wealth of Michael Polansky, revealing a financial architect of considerable sophistication.

His career trajectory shows a masterful progression from a skilled analyst at elite institutions like Bridgewater and Founders Fund ⁵ to a trusted operational partner for a tech billionaire, and finally to a principal building his own financial empire.

He has not relied on a single source of wealth but has built a diversified, synergistic ecosystem.

He leverages the platform and capital of the Parker empire to operate at a massive scale, while simultaneously channeling his expertise into his own investment funds and entrepreneurial ventures.

This multi-pillar strategy, combining high-level executive operation, public and private market investing, and direct entrepreneurship, is the blueprint for how his formidable net worth has likely been constructed.

While the precise figure remains private, the analysis confirms that Michael Polansky is, without question, a significant and highly successful figure in the worlds of technology, finance, and investment.

Works cited

1. Michael Polansky: The net worth, age, business ventures, and more of Lady Gaga’s fiancé, accessed on August 4, 2025, https://www.prestigeonline.com/my/people/michael-polansky-net-worth-age-lady-gaga-fiance/
2. Who Is Michael Polansky? Lady Gaga’s Business Mogul Fiancé, accessed on August 4, 2025, https://www.ceotodaymagazine.com/2025/02/meet-michael-polansky-the-business-genius-engaged-to-lady-gaga/
3. Who Is Michael Polansky? Meet Lady Gaga’s Tech Entrepreneur Fiancé – Grazia, accessed on August 4, 2025, https://graziadaily.co.uk/celebrity/news/lady-gaga-boyfriend-michael-polansky/
4. Lady Gaga & Michael Polansky’s Combined Net Worth: Exploring The Joker 2 Star & Her Beau’s Colossal Fortune Amid The Engagement Declaration – Koimoi, accessed on August 4, 2025, https://www.koimoi.com/fashion-lifestyle/lady-gaga-michael-polanskys-combined-net-worth-exploring-the-joker-2-star-her-beaus-colossal-fortune-amid-the-engagement-declaration/
5. Michael Polansky – Partner – Alpha Access – Unless, accessed on August 4, 2025, https://www.unless.co/team/michael-polansky
6. Michael Polansky joins 7GC as Senior Advisor to the Firm — 7gc&co, accessed on August 4, 2025, https://www.7gc.co/news/michael-polansky-joins-7gc-as-senior-advisor-to-the-firm
7. Michael Polansky – Co-founder; Board Member at Parker Institute for Cancer Immunotherapy, accessed on August 4, 2025, https://theorg.com/org/parker-institute-for-cancer-immunotherapy/org-chart/michael-polansky
8. Hawktail • Seed Stage VC, accessed on August 4, 2025, https://hawktail.com/
9. Outer Biosciences, accessed on August 4, 2025, https://www.outerbio.com/
10. Net Worth Calculator: What’s My Net Worth? – Forbes Advisor, accessed on August 4, 2025, https://www.forbes.com/advisor/investing/financial-advisor/net-worth-calculator/
11. Net Worth: What It Is and How to Calculate It – Investopedia, accessed on August 4, 2025, https://www.investopedia.com/terms/n/networth.asp
12. Make It Your Resolution To Figure Out Your Net Worth – Forbes, accessed on August 4, 2025, https://www.forbes.com/councils/forbesfinancecouncil/2020/01/27/make-it-your-resolution-to-figure-out-your-net-worth/
13. ELI5: how are Forbes able to estimate/calculate the wealth of the people on their billionaires list and how accurate is it? : r/explainlikeimfive – Reddit, accessed on August 4, 2025, https://www.reddit.com/r/explainlikeimfive/comments/2z0n6a/eli5_how_are_forbes_able_to_estimatecalculate_the/
14. Private vs. Public Company: What’s the Difference? – Investopedia, accessed on August 4, 2025, https://www.investopedia.com/ask/answers/difference-between-publicly-and-privately-held-companies/
15. Navigating the Valuation of Public and Private Companies – Andersen in Egypt, accessed on August 4, 2025, https://eg.andersen.com/valuation-public-private-companies/
16. Demystifying the Forbes 400 and the Bloomberg Billionaires Index – Helen Brown Group, accessed on August 4, 2025, https://www.helenbrowngroup.com/demystifying-the-forbes-400-and-the-bloomberg-billionaires-index/
17. Compendium of Federal Estate Tax and Personal W ealth Studies – IRS, accessed on August 4, 2025, https://www.irs.gov/pub/irs-soi/11pwcompench7ewealth.pdf
18. How to Value Private Companies – Investopedia, accessed on August 4, 2025, https://www.investopedia.com/articles/fundamental-analysis/11/valuing-private-companies.asp
19. 18 Differences Between Valuing Public and Private Businesses – Morgan & Westfield, accessed on August 4, 2025, https://morganandwestfield.com/knowledge/18-differences-between-valuing-public-and-private-businesses/
20. The CEO’s Perspective: What Public Companies and Private Equity Can Learn from Each Other – Spencer Stuart, accessed on August 4, 2025, https://www.spencerstuart.com/research-and-insight/the-ceos-perspective-what-public-companies-and-private-equity-can-learn-from-each-other
21. Equity Compensation in Private vs. Public Companies: Key Differences for Execs – FW Cook, accessed on August 4, 2025, https://www.fwcook.com/Blog/Equity-Compensation-in-Private-vs-Public-Companies-Key-Differences-for-Execs/
22. Initial Founding Gift: $600 million Entities: The Parker Foundation is …, accessed on August 4, 2025, https://parker.org/assets/downloads/press-kit/17_Parker-Foundation-Fact-Sheet.pdf
23. Michael Polansky – Bloomberg Tech Conference 2016 – Sched, accessed on August 4, 2025, https://bloombergtechconference2016.sched.com/speaker/michael_polansky.1vahr5gi/list/descriptions/
24. Parker Institute for Cancer Immunotherapy, accessed on August 4, 2025, https://www.mskcc.org/research-programs/parker-institute-cancer-immunotherapy
25. Parker Institute For Cancer Immunotherapy – Nonprofit Explorer – ProPublica, accessed on August 4, 2025, https://projects.propublica.org/nonprofits/organizations/473355381
26. AVOS CAPITAL MANAGEMENT, LLC | Form ADV – Radient Analytics, accessed on August 4, 2025, https://radientanalytics.com/firm/adv/avos-capital-management-llc-313979
27. Avos Capital Management, LLC Portfolio Holdings – Fintel, accessed on August 4, 2025, https://fintel.io/i/avos-capital-management-llc-9824
28. Avos Capital Management LLC Fund Performance History & Annualized Return, accessed on August 4, 2025, https://hedgefollow.com/funds/Avos+Capital+Management+LLC/Performance-History
29. fintel.io, accessed on August 4, 2025, https://fintel.io/i/avos-capital-management-llc-9824#:~:text=Latest%20Holdings%2C%20Performance%2C%20AUM%20(,(which%20is%20not%20disclosed).
30. Hawktail – Capital tracker – ReFED Insights Engine, accessed on August 4, 2025, https://insights-engine.refed.org/capital-tracker/funders/hawktail—palo-alto-california?backTo=%2Fcapital-tracker%2Ffunders%2Fprelude-ventures—san-francisco-california%3FbackTo%3D%252Fsolution-provider-directory%252Fpart-of-the-solution—new-york-usa
31. Hawktail investment portfolio – PitchBook, accessed on August 4, 2025, https://pitchbook.com/profiles/investor/472206-34
32. HAWKTAIL MANAGEMENT, LLC | Form ADV – Radient Analytics, accessed on August 4, 2025, https://radientanalytics.com/firm/adv/hawktail-management-llc-321161
33. Outer Biosciences – Work in biotech, accessed on August 4, 2025, https://workinbiotech.com/companies/outer-biosciences
34. Automation Engineer – Outer Biosciences – Jobs in Malden, MA | OpenJobs AI, accessed on August 4, 2025, https://www.openjobs-ai.com/jobs/automation-engineer-malden-ma-621863
35. Outer Biosciences – 2025 Company Profile, Funding & Competitors – Tracxn, accessed on August 4, 2025, https://tracxn.com/d/companies/outer-biosciences/__vrw6ohOPggrGTP3WpGTzF5WLvkAyT1vXEURvNyMVJQU
36. Outer Biosciences 2025 Company Profile: Valuation, Funding & Investors | PitchBook, accessed on August 4, 2025, https://pitchbook.com/profiles/company/510763-06
37. Outer Biosciences – 2025 Funding Rounds & List of Investors – Tracxn, accessed on August 4, 2025, https://tracxn.com/d/companies/outer-biosciences/__vrw6ohOPggrGTP3WpGTzF5WLvkAyT1vXEURvNyMVJQU/funding-and-investors
38. Lady Gaga attends house party in Minnesota with fiancé Michael Polansky – CBS News, accessed on August 4, 2025, https://www.cbsnews.com/minnesota/news/lady-gaga-attends-house-party-in-minnesota-with-fiance-michael-polansky/
39. Michael Polansky – Wikipedia, accessed on August 4, 2025, https://en.wikipedia.org/wiki/Michael_Polansky